Abstract
Abstract
Objective
It is often believed that pregnant women who use illicit substances are more likely to experience psychosocial issues like smoking, depression, and inadequate health care compared to pregnant women who do not. However, the prevalence of these psychosocial issues has rarely been calculated and compared using nationally representative data.
Methods
Important psychosocial issues identified by the American College of Obstetricians and Gynecologists were operationalized using variables in the National Survey on Drug Use and Health. We report weighted prevalence and age-adjusted odds ratios for these issues in pregnant women who did vs. did not report past-month illicit substance use.
Results
Pregnant women (n = 3,657) who reported past-month illicit substance use (6.3%; 95% CI 5.4-7.0) had significantly higher rates of almost all psychosocial issues examined, including past-month cigarette smoking (44.9% vs. 6.5%; age-adjusted odds ratio (AOR) = 7.14 (95% CI 4.98–10.20)); past-month alcohol use (36.1% vs. 7.8%; AOR = 6.80 (4.69, 9.86)); serious past-month distress (23.0% vs. 5.0%; AOR = 4.99 (3.07–8.11)); no health insurance (11.7% vs. 6.2%; AOR = 1.79 (1.07–2.99)); and receipt of food stamps (45.0% vs. 24.0%; AOR = 2.26 (1.55–3.29)). Moving 3 + times in the past year followed a similar pattern, but results were compatible with there being no difference between groups (10.6% vs. 5.5%; AOR = 1.59 (0.95–2.66)). In contrast to other issues examined, English language proficiency was higher among those who reported illicit substance use (4.7% vs. 0.4%; AOR = 0.08 (0.01–0.63)).
Conclusions
Pregnant women who use illicit substances experience higher rates of most psychosocial issues compared to those who do not, reinforcing recommendations for multidisciplinary approaches to care.
Funder
National Institute on Drug Abuse
Publisher
Research Square Platform LLC
Reference21 articles.
1. American College of Pediatrics and American College of Obstetricians and Gynecologists. (2017). Guidelines for Perinatal Care (S. Kilpatrick & L.-A. Papile, Eds.; 8th ed.). https://www.acog.org/clinical-information/physician-faqs/-/media/3a22e153b67446a6b31fb051e469187c.ashx
2. Psychiatric Co-Morbidities in Pregnant Women with Opioid Use Disorders: Prevalence, Impact, and Implications for Treatment;Arnaudo CL;Current Addiction Reports,2017
3. Drug use and pregnancy - challenges for public health;Gyarmathy VA;Euro Surveillance: Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin,2009
4. Short screening scales to monitor population prevalences and trends in non-specific psychological distress;Kessler RC;Psychological Medicine,2002
5. Screening for serious mental illness in the general population with the K6 screening scale: results from the WHO World Mental Health (WMH) survey initiative;Kessler RC;International Journal of Methods in Psychiatric Research,2010